[Progress in diagnosis of and therapy for diabetic ketoacidosis].
Hisatomi
Akitaka
A
D001639:Bicarbonates / Q000009:adverse effects; D015415:Biomarkers / Q000097:blood / Q000652:urine; D001929:Brain Edema / Q000209:etiology; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D016883:Diabetic Ketoacidosis / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D004040:Dietary Carbohydrates / Q000009:adverse effects; D005440:Fluid Therapy; D006801:Humans; D017674:Hypophosphatemia / Q000209:etiology; D007038:Hypotonic Solutions / Q000009:adverse effects; D007328:Insulin / Q000008:administration & dosage; D007552:Isotonic Solutions / Q000008:administration & dosage; D007657:Ketone Bodies / Q000097:blood / Q000652:urine; D011188:Potassium / Q000008:administration & dosage
D001639:Bicarbonates; D015415:Biomarkers; D004040:Dietary Carbohydrates; D007038:Hypotonic Solutions; D007328:Insulin; D007552:Isotonic Solutions; D007657:Ketone Bodies; D011188:Potassium